Introduction
Multivalent interactions between carbohydrates and lectins play key roles in the initiation and control of numerousb iological and pathological processes.
[1] For these reasons, al arge panel of synthetic scaffolds [2] decorated with clusters of identical sugar residues, namely homoglycoclusters, have been developedo ver the last decadea nd successfully used as antiadhesive agents,i mmunomodulators, or diagnostic tools. [3] However,t hese compounds barely reflect the heterogeneity of the glycocalix, which limits their utility to decipher the most complex recognition processes and to develop more active and selective probes.
[4] Recently,afew reports highlighted the interest of heteroglycoclusters (hGCs), which display differents ugar units, as they represent attractive tools to deepen the understanding of the influenceo fh eterogeneous sugar display on biological systems. [5] Unlike homoclusters, for which an umber of potent synthetic methodsa re available, the assembly of structurally well-defined hGCs remainsc hallenging, even thoughafew procedures have been described so far.T he most efficient methods rely on the use of orthogonal chemoselectivel igations, which allow the controlled conjugation of sugar epitopes onto properly functionalized scaffolds. For example,our group has previously described the synthesis of tetravalent hGCsb ased on clickable cyclopeptides caffolds decorated with two non-identical sugar residues,e ither in 2:2o r 3:1r elative proportions, which were obtained in as tepwise protocolc ombining oxime ligation (OL) and Cu I -catalyzed azide-alkyne cycloaddition (CuAAC). [6] Subsequently,w eh ave demonstrated the orthogonality of both thiol-ene and thiolchloroactetyl couplings (TEC and TCC, respectively) for the synthesis of hexavalent hGCs that display two different sugars, in a4 :2 relative proportion and in the two possible orientations on the scaffold. [7] More recently,w eh ave reported, fort he first time, am ulti-click protocol involving four different conjugation methods:O L, TEC, CuAAC, andT CC. [8] By using ap roperr eaction order,t his approach gave access to unprecedented tetravalent hGCs, displaying four different sugar motifs in as equential one-pot assembly in excellent yields and with as ingle purificationstep.
With the aim to design an ew series of cyclopeptide-based glycoclusters, we synthesized diverset etravalent homoglycoclusters and hGCs, and then octavalent structures from these building blocks were prepared by using ac onvergent protocol. Owing to their involvement in numerous biological and pathological recognition events, we focused our attention on 5-N-acetyl-neuraminic acid (Neu5Ac), N-acetyl glucosamine (GlcNAc), and galactose (Gal).
[9] In fact, we have introduced propargyl Neu5Ac on ac yclopeptide scaffold with four azide groups through CuAAC, whereas GlcNAc thiol units have been coupled on as caffold displaying four allyloxycarbonyl (Alloc) groups,u sing TEC. Alternatively,acombination of both reactions have been used to generate tetravalent hGCs displaying The synthesis of heteroglycoclusters (hGCs) is being subjected to rising interest, owing to their potentialapplications in glycobiology.I nt his paper,w er eport an efficient ands traightforward convergent protocol based on orthogonal chemoselective ligations to prepares tructurally well-definedc yclopeptidebased homo-and heterovalent glycoconjugates displaying 5-N-acetyl-neuraminic acid (Neu5Ac), galactose (Gal), and/or Nacetyl glucosamine (GlcNAc). We first used copper-catalyzed azide-alkyne cycloaddition and/or thiol-enec oupling to conjugate propargylated a-sialic acid 3, b-GlcNAc thiol 5,a nd b-Gal thiol 6 onto cyclopeptides caffolds 7-9 to preparet etravalent homoglycoclusters (10-12)a nd hGCs (13) (14) w ith 2:2c ombinations of sugars. In addition, we have demonstratedt hat 1,2-diethoxycyclobutene-3,4-dione can be used as ab ivalent linker to preparev arious octavalent hGCs ( 16, 19 ,a nd 20)i nacontrolled manner from thesetetravalent structures.
Neu5Ac, Gal, and/or GlcNAc( 2:2c ombination). Furthermore, to obtain two series of octavalent hGCs (4-4 and2:2-2:2 combinations),1 ,2-diethoxycyclobutene-3,4-dione, namely diethyl squarate (DS), was used as al inker to undergo selective couplings with the pending amine of those tetravalent scaffolds. The utilization of CuAAC, TEC, and DS coupling (DSC) in an orthogonal sequential protocol has not yet been reported.
Results and Discussion

Synthesis of Tetravalent Homo-and Heteroclusters10-14
Three clickable carbohydrate buildingblocks, namely propargyl sialoside 4,G lcNAc thiol 5, [10] and galactose thiol 6, [10] have been prepared. The synthesis of propargyl sialoside 4 was adaptedf rom the procedure described by Gan and Roy,w ho have reported the synthesis of the acetyated derivativeo fasialoside propargyl 3 by using aK oenigs-Knorr glycosylation (Scheme 1). [11] Commercially available N-acetyl neuraminic acid 1 was treated with dry MeOH in the presence of Dowex resin (H + ), and then successively with acetyl chloride (saturated with HCl gas) at room temperature to give derivative 2 in good yield. Next, ag lycosylation of derivative 2 with distilled propargyl alcohol in the presence of AgOTfa nd moleculars ieves provided an anomericm ixture of propargyl sialoside, from which the alpha anomer 3 was obtained in 68 %y ield after successive recrystallization in cold diethyl ether.The appearance of ac haracteristic triplet in the 1 HNMR spectrum at 2.45 ppm (J = 4.0 Hz), corresponding to the alkyne proton, and of as ignal at 98.1 ppm in the 13 CNMR spectrum for C-2 confirmed the presence of the a-linkedp ropargyl functionalityi nc ompound 3.D e-O-acetylation with NaOMe and methyl ester hydrolysis with LiOH afforded compound 4 in 85 %y ield overtwo steps.
With these compounds in hand, we next synthesized several cyclopeptides caffolds by using solid-phase peptide synthesis followed by cyclizationo ft he linear peptidei ns olution. Two scaffoldsd isplayingf our azide (7) [12] or allyloxycarbonyls (8) groups and one scaffold with acombinationo ft wo allyloxycarbonyl and azide groups 9 have thus been prepared (Scheme 2).
We first decided to perform the CuAAC reaction with the propargyl glycosides 4 and the scaffold 7 in the presence of copperm icropowder in am ixture of isopropanol and sodium acetate buffer pH 7.4, as recently used in our group. [13] Althoughthe reaction was successful with other propargyl glycosides, no trace of the expected compound 10 was obtained by using propargyl sialoside 4 under these experimental conditions. We, thus, decided to perform the same reactiona tr oom temperature in phosphate-buffered saline (PBS) pH 7.4. The reaction was followed by analytical HPLC and UPLC-MS, and was found to be complete after 2h,p roviding the tetravalent glycocluster 10 in al ow yield (ca. 10 %) after preparative HPLC. Surprisingly,t he utilization of am ixture of DMF and PBS (pH 7.4, 1:1, v/v) was found to be less efficient and led to product decomposition after 2h.I ts hould be mentioned that, unlike other carbohydrates, the preparation of sialylated conjugates is more frequently described with fully protected propargyl sialoside, except in af ew cases. [14] For example, Dondoni and co-workersh ave reported the synthesis of calix[4]arene appended sialoclustersf rom acetylated propargyl thiosialoside and calixarene azides with good yields. [15] For this reason, we hypothesized that the presence of the free carboxylic acid group in 4 might be the reasono ft hesed ifficulties. To confirm this, we decided to perform the CuAACreactionwith the propargyl sialoside (3)p rotected as am ethyl ester insteado f4.A s expected, we were able to obtain the desired tetravalent glycocluster 11 in the presence of Cu micropowder in PBS (pH 7.4) in 69 %y ield after RP-HPLC purification. Finally,t etravalent homoglycocluster 12 was prepared in 83 %y ield by treatingc yclopeptide 8 with GlcNAc thiol 5 in the presence of 2,2-dimethoxy-2-phenylacetophenone (DMPA) under UV irradiation (l max 365 nm), as reported previously. [15, 16] Next, TEC and CuAACw eres equentially used to preparet he hetero-tetravalent compounds 13 and 14,a st he orthogonality of these two reactions has been demonstrated previously by Dondoni and co-workers. [15] In addition, we have determined the best reaction sequence is to use both reactions in ao nepot fashion. [8] Accordingly,w ef irst performed the photoinduced (l = 365 nm) addition of GlcNAct hiol 5 (1.5 equiv per Alloc) on cyclopeptide 9 under UV irradiation in the presence of 2,2-dimethoxy-2-phenylacetophenone (DMPA) as ar adical initiator in water/DMF (2:1, v/v) for 45 min. The CuAAC ligation was subsequently carried out by adding to the crude reaction mixture propargyl sialoside 3 (1.6 equiv per azide) in the presence of Cu micropowder (4-5 equiv per azide)i nP BS. This process gave the desired tetravalent glycoclusters 13 and 14 in 71 and 69 %o verall yield after purification,respectively.
Synthesis of Octavalent hGC 16
Al arge number of artificial scaffolds that include carbohydrates, [17] peptides, [18] proteins, [19] polymers, [20] liposomes, [21] dendrimers, [22] nanostructures, [23] or calyx[4]arenes [24] have been exployedt oc onjugate multiple copieso fs ialoglycans, and the resultingg lycoclustersh ave shown interesting binding efficiencies, particularlyi nt he hemagglutination assay against influenza Av iruses. In general, the strengtho fc arbohydrate-protein interactions is closely dependent on the ligand structure. Many studies in this field have demonstrated that valency,l inker structure, and scaffold geometry are also importantparameters to consider in order to achieve high affinity.O ur group has recently investigated the influence of these parameters in the binding efficiency between 4-, 16-and 64-valent series of glycocyclopeptides and diverse vegetal and bacterial lectins. [25] Here, we extended the scope to generate the structural diversity of these compounds by preparing an ew series of octavalent heteroclusters. For this, we focused our attention on DS, which is used in av arietyo fs equentiala midation reactions by tuning the pH of the reactionm ixture. [26] In fact, this linker appears ideal to selectively conjugate the previous scaffolds 11-14 in two steps, whicha ll contain ap ending amineg roup. We first studied the reaction between compound 12 and DS in am ixture of Na 2 CO 3 buffer (pH 8) andE tOH or DMF,a sr eported by Kunz and co-workers.
[27] However, we found this procedure to be unsuccessful, presumably owing to solubility aproblem. Instead, we determined that the treatment of 12 with DS (1.1 equiv) in the presence of N,N-diisopropylethylamine (DIPEA)a tpH 8.5 in DMF at room temperature led to the formationo fm ono-amido ester 15 as the unique product after 4hof reactionwith 88 %y ield (Scheme 3). We next performed the second amidation reactiont oa fford the octavalent compound 16 by using as light excess of glyco-cluster 11 (1.5 equiv) in sodium phosphate buffer (pH 9.5) at 37 8C. This reaction was found to be slow and low yielding; moreover,t he partial hydrolysis of methyl esters of Neu5Ac moieties was also observed by UPLC analysis.T oa void this problem,w edecided to use sodium carbonate buffer pH 9.5 insteado fs odium phosphate buffer to perform the second amidation and concomitant full deprotection of the methyl esters. Under thesec onditions,c ompound 16 was obtained in a6 3% yield after semi-preparative HPLC purification, along with the formation of compound 10 in a3 1% yield as as ide product.
With the aim to prepare Neu5Ac-containing heteroclusters with different geometrical distributionst o16,w es ynthesized compounds 19 and 20,d isplaying Neu5Ac with GlcNAc and Gal residues, respectively,a ta lternating positions on the cyclopeptides caffold, following the protocol described above (Scheme 4).
Compound 17 was first prepared in an 87 %y ield from hGC 13 (1 equiv) and 1,2-diethoxycyclobutene-3,4-dione (1.1 equiv) in DMF at room temperature. After purification with semi-preparative HPLC, the addition of as light excess of compound 13 (1.5 equiv) in the presence of sodium carbonate buffer at 37 8C afforded compound 19 in 67 %y ield. Similar treatment of compound 14 under identicalc onditions afforded the desired heterocluster 20 in a68% yield.
Conclusions
An efficient and straightforward protocolf or the controlled synthesis of multivalent homo-a nd hGCs has been developed. This convergent protocol is based on the use of three different chemoselective ligations that are CuAAC, TEC, and squaric acid diestera st he central core. We first demonstrated that tetravalent homo-and heteroglycocluster precursors can be synthesized in high yield by using Cu-micropowder-catalyzed azidealkyne cycloadditon,t hiol-ene coupling reaction, or both, using propargyl sialoside 3 and GlcNAc thiol 5,o rg alactoside 6 and cyclopeptides 7, 8,a nd 9,r espectively.D uring the process, an alternative method to synthesize propargyl sialoside 4 through silver-triflate-mediated Koenigs-Knorr glycosylation was also developed in ag ood yield. Furthermore, we also described that squaric acid diesterr epresents as imple and versatile linker to connect two amine-terminated glycoclusters through two consecutive coupling reactions at basic pH. The overall protocol gave access to octavalent hGCs in good yields and purity.T hiss ynthetic approacht ogether with our previous reports in this field represent versatile synthetic tools to develop original series of structurally well-definedh omo-and heteroglycodendrimers with promising biological properties. In particular,w eare currently exploring the best chemoselective ligation sequences to prepare multi-antigenic vaccines composed of tumor-associated carbohydrate and peptideantigens.
Experimental Section General Procedures
All chemical reagents were purchased from Aldrich (Saint Quentin Fallavier,F rance) or Acros (Noisy-Le-Grand, France). All protected amino acids and Fmoc-Gly-Sasrin resin were obtained from Advanced ChemTech Europe (Brussels, Belgium). For peptides and glycopeptides, analytical RP-HPLC was performed on aW aters system equipped with aW aters 2695 separations module and aW aters 2487 Dual Absorbance UV/Vis Detector.A nalysis was carried out at 1.0 mL min À1 (EC 125/3 nucleosil 300-5 C 18 )w ith UV monitoring at 214 and 250 nm by using al inear A-B gradient (buffer A: 0.09 %C F 3 CO 2 Hi nwater;b uffer B: 0.09 %C F 3 CO 2 Hi n9 0% acetonitrile). Purifications were carried out at 22.0 mL min À1 (VP 250/21 nucleosil 100-7 C 18 )w ith UV monitoring at 214 and 250 nm by using al inear A-B gradient. For carbohydrate derivatives, moisture-sensitive reactions were performed under an argon atmosphere by using oven-dried glassware and reactions was monitored by using TLC with silica gel 60 F254 precoated plates (Merck). Spots were inspected by UV light and visualized by charring with 10 %H 2 SO 4 in EtOH for carbohydrates. Silica gel 60 (0.063-0.2 mm or 70-230 mesh, Merck) was used for column chromatography. H), assignments were performed by using GCOSY and GHMQC experiments. Standard abbreviations s, d, t, dd, br s,m refer to singlet, doublet, triplet, doublet of doublet, broad singlet, multiplet, respectively.T he anomeric configuration was established from J 1,2 coupling constants. HRMS and ESI-MS spectra of peptides and gly- www.chemistryopen.org copeptides were measured on an Esquire 3000 spectrometer from Bruker or on an Acquity UPLC/MS system from Waters equipped with an SQ Detector 2. MALDI-TOFe xperiments were performed on aA utoFlex IB ruker after sample pretreatment in an OligoR3 microcolumn (Applied Biosystems, USA) using 2,5-dihydroxybenzoic acid matrix.
Synthesis of PropargylS ialoside (4)
Methyl (5-Acetamido-4,7,8,9-tetra-O-acetyl-2-chloro-2,3,5-trideoxy-d-glycereo-b-d-galacto-2-nonulopyranosid)onate (2) Dowex-50WX2 resin (1 g, H + form) was added to as olution of Nacetyl neuraminic acid 1 (2 g, 6.5 mmol) in dry MeOH (100 mL) at room temperature under an argon atmosphere. The reaction mixture was stirred for 18 ha nd the resin was filtered through aC elite pad, washed with dry methanol (10 mL), and the filtrate was evaporated under vacuum to give awhite solid. The crude reaction mixture was used for next reaction without further purification. Acetyl chloride (50 mL) was added to the crude reaction mixture at room temperature under an HCl (gas) environment. The white suspension gradually became pale pink and the reaction mixture was stirred continuously for 12 h. The solvents were removed in vacuo, co-evaporated with toluene (2 50 mL), and the residue was purified by flash chromatography (SiO 2 )t oafford 2 (2.81 g, 85 %) as aw hite solid. R f = 0.33 (MeOH/CH 2 Cl 2 = 24:1). The NMR data is consistent with literature. [28] 
Methyl (Prop-2-ynyl 5-acetamido-3,5-dideoxy-d-glycero-a-dgalacto-2-nonulopyranosid)onate (3)
Am ixture of 2 (2.81 g, 5.5 mmol), AgOTf (2.1 g, 8.2 mmol) and powdered 4 molecular sieves (4 g) in freshly distilled propargyl alcohol (60 mL) was stirred at room temperature under an Ar atmosphere. The reaction mixture was protected from light and stirred for 2h in the dark. The crude mixture was filtered through aC elite pad, washed with CH 2 Cl 2 (2 50 mL), and the filtrate was concentrated under vacuum to dryness. The residue was dissolved in CH 2 Cl 2 (500 mL), washed with water (2 200 mL), brine (100 mL), and aqueous Na 2 S 2 O 3 (10 %m /v). The combined organics were dried over MgSO 4 ,f iltered, and the solvent removed in vacuo. The crude was purified by using flash chromatography (SiO 2 )a nd crystallized from diethyl ether at À4 8Ct og ive the peracetylated precursor of 3 (1.98 g, 68 %) as ac olorless solid. 
GeneralP rocedure for Solid-Phase Peptide Synthesis
Assembly of the protected linear peptide was performed manually by employing as olid-phase peptide synthesis (SPPS) protocol using the Fmoc/tBu strategy and the Fmoc-Gly-Sasrin TM resin. Coupling reactions were performed by using, relative to the resin loading, 2equivalents of N-Fmoc-protected amino acid activated in situ with PyBOP (2 equiv) and DIPEA (5 equiv) in DMF (10 mL g À1 resin) for 30 min. The coupling reaction was checked by using the TNBS test with as olution of 1% trinitrobenzenesulfonic acid in DMF. NFmoc protecting groups were removed upon treatment with piperidine-DMF (1:4, 10 mL g À1 resin) for 10 min. The process was repeated three times and the resin was further washed five times with DMF (10 mL g À1 resin) for 2min. The peptide was released from the resin by treating ten times with ac leavage solution of TFA/CH 2 Cl 2 (1:99). The combined cleavage fractions were concentrated under reduced pressure;i ce-cold Et 2 Ow as added to induce precipitation and the linear peptide was obtained as aw hite powder after filtration and used without any further purification.
GeneralP rocedure for PeptideCyclization
All linear peptides were dissolved in CH 2 Cl 2 (0.5 mm)a nd the pH of the solution was adjusted to 8.5-9 by addition of DIPEA. PyBOP (1.2 equiv) was added and the reaction mixture was stirred at room temperature for 1h.T he solvent was removed under reduced pressure and precipitation from diethyl ether afforded desired Boc-protected cyclic peptides as white solids. Boc-protected cyclic peptides were treated with as olution of TFA/CH 2 Cl 2 (10 mL, 3:2, v/v) for 1h;t he crude reaction mixture was concentrated to afford -NH 2 terminated cyclic peptides 7-9.
Compound 8
The linear peptide sequence A (0.49 mmol) (see Scheme 1i nt he Supporting Information) was synthesized following the general procedure for SPPS, then cyclized, and finally the Boc group was cleaved. Yield:9 0% (over three steps, 569 mg) after purification by preparative RP-HPLC and lyophilization;R P-HPLC:R t = 7.6 min (C 18 , l = 214 nm 5-100 %Bin 15 
General Procedure for CuAACL igation
As olution of cyclopeptide and propargyl sialoside (1.5-1.8 equiv/ N 3 )i nP BS buffer (10 mm,p H7.4) was degassed at room temperature under an Ar atmosphere for 15 min. Copper micropowder (4-5equiv/N 3 )w as added to the reaction mixture under an itrogen atmosphere and the solution was vigorously stirred at room temperature. After 45 min, analytical HPLC indicated complete coupling. Chelex TM resin was added to remove excess copper and the solution was filtered, concentrated, and purified by using RP-HPLC to afford pure compound as aw hite powder after lyophilization.
General Procedure for TEC Ligation
To as olution of cyclopeptide (1-5 mm)a nd thiol glycoside (1.5-1.8 equiv/allyl) in am ixture DMF/H 2 O( 2:1), 2,2-dimethoxy-2-phenylacetophenobe (DMPA, 2-3 mg) was added and the solution was irradiated at 365 nm for 45 min while stirring. The reaction was directly purified by using semi-preparative RP-HPLC to afford pure compound as white foam after lyophilization.
General Procedure for DSC Ligation
Procedure A: mono-Amido Ester Formation
To as olution of amino-containing cyclopeptide (1-5 mm)a nd 1,2-diethoxycyclobutene-3,4-dione (1.1 equiv) in DMF,D IPEA was added at room temperature to reach pH 8.5. After 4h of stirring, analytical RP-HPLC showed mono-amide product formation, the crude mixture was then purified by using semi-preparative RP-HPLC to afford the desired compound as aw hite foam after lyophilization.
Procedure B: bis-Amido Ester Formation
To as olution of squaric acid mono-amide compound (1-5 mm)i n sodium carbonate buffer (pH 9.5), amino-containing cyclopeptide (1.1-1.5 equiv) was added at room temperature. The reaction mixture was incubated at 37 8Ca nd the evolution was monitored by using analytical RP-HPLC. After 1day,t he crude reaction mixture was purified by using semi-preparative RP-HPLC to give the desired compound as awhite foam after lyophilization. 
Compound 11
Compound 13
Following the procedure for TEC ligation, compound 9 (10.0 mg, 8.3 mmol) was reacted with 5 10 (5.9 mg, 25.0 mmol) in the presence of 2,2-dimethoxy-2-phenylacetophenone (DMPA, 2.6 mg, 10.1 mmol). After 45 min, the crude reaction mixture was concentrated under reduced pressure, the residue was dissolved in PBS buffer (1.0 mL, pH 7.4, 10 mm), and then 3 (10.8 mg, 29.9 mmol) was added to this solution. The coupling was performed by following the general procedure for CuAAC ligation. After crude mixture purification through semi-preparative RP-HPLC, compound 13 was obtained in 71 %y ield (14.4 
Compound 14
Compound 14 was obtained in 70 %y ield (13.7 mg) from 9 (10.0 mg, 8.3 mmol), 6 [10] (4.9 mg, 24.9 mmol) and 3 (9.6 mg, 26.6 mmol), following the same strategy used for compound 13. 
Compound 16
Compound 16 was obtained by coupling compound 15 (3.9 mg, 1.6 mmol) with compound 11 (6.2 mg, 2.4 mmol), following procedure A for the DSC coupling, in 63 %y ield (5.0 mg) as aw hite foam after lyophilization. Compound 10 (1.5 mg, 0.5 mmol, 31 %) was also obtained as by-product. RP-HPLC:R t = 7.2 min (C 18 , l = 214 nm 0-60 %Bin 15 min);E SI lowing procedure A for the DSC coupling, in 87 %y ield (4.0 mg) as aw hite foam after lyophilization. RP-HPLC:R t = 7.9 min (C 18 , l = 214 nm 0-60 %Bin 15 min);E SI + -MS m/z:c alcd for C 107 
Compound 18
Compound 18 was obtained by coupling 14 (6.0 mg, 2.6 mmol) with 3,4-diethoxy-3-cyclobutene-1,2-dione (410 mL, 2.8 mmol), following procedure A for the DSC coupling, in 85 %y ield (5.5 mg) as aw hite foam after lyophilization. RP-HPLC:R t = 7.6 min (C 18 , l = 214 nm 0-60 %Bin 15 min);E SI + -MS m/z:c alcd for C 103 
